Porda Havas International Financial Communications Group
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Baguio wins EPD service contract worth HK$37 million to provide food waste collection services in New Territories West 2023-01-16 20:41
PAAMC HK Announces Winning in ESG Leading Enterprise Awards 2022 2022-12-14 16:30
Baguio wins FEHD contracts worth HK$482 million driving total Contracts on Hand to a historical high level 2022-09-30 17:51
PAAMC HK Honored to be Included in 4 Prestigious IAMAC Recommendations 2022-09-27 16:30
Baguio's Net Profit Increased by 45% 2022-08-30 23:01
Ocumension Releases its 2022 Interim Report with its core product Youshiying® being approved for marketing, continuously accelerating product commercialization 2022-08-26 22:09
SZSE Issued Evaluation Method of ESG and ESG Indices to Improve SZSE Characteristic Index System and Provide Services to Low-Carbon and Sustainable Development 2022-08-11 16:33
Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration 2022-06-23 12:19
An In-Depth Look at the Annual Performance of SZSE Core Indices Constituent Companies 2022-06-06 19:38
SZSE Makes New Progress in Implementing High-standard Two-way Opening-up ChiNext Index Becomes an Important Target for Foreign Investors to Invest in China A-shares 2022-06-02 17:30
Ping An Overseas Holdings Announces Successfully Raising USD 300 Million for China New Economy Fund 2022-05-18 16:15
Peijia Medical Announces 2021 Annual Results 2022-04-02 00:06
Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma 2022-02-23 17:53
Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC) 2022-02-16 17:04
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors 2022-02-09 17:12
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors 2022-02-09 17:10
Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd. 2022-01-21 11:12
Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance Leads Investment in Xuanzhu Biopharm 2022-01-03 14:24
PAAMC HK Announces Winning in ESG Leading Enterprise Awards 2021 2021-11-17 18:02
Ping An Overseas Holdings Raised Funds of USD 750 Million for Overseas Private Equity Investing 2021-10-25 18:22
1 2 3 4 5 17